PREMIER NUTRA PHARMA Inc. – FDA 483, Jul 8, 2022
PREMIER NUTRA PHARMA Inc. in Carlsbad, CA, a drug manufacturer, was inspected and found to have significant deficiencies across its quality control, manufacturing processes, and facility maintenance. Key issues include releasing contaminated products without proper testing, lacking essential batch records and quality unit oversight, and maintaining unsanitary conditions. These conditions pose a public health risk due to potential product contamination.
ID · d6436604-4f64-4382-9093-45bdef639ed6
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.